Patent details

EP2309985 Title: PHARMACEUTICAL COMPOSITION

Basic Information

Publication number:
EP2309985
PCT Application Number:
JP2009063708
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097880132
PCT Publication Number:
WO2010013823
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION
French Title of Invention:
COMPOSITION PHARMACEUTIQUE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG
SPC Number:

Dates

Filing date:
27/07/2009
Grant date:
14/03/2018
EP Publication Date:
20/04/2011
PCT Publication Date:
04/02/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/03/2018
EP B1 Publication Date:
14/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/07/2018
Expiration date:
27/07/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/03/2018
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

Inventor

1

Name:
NONOMURA, Muneo
Address:
Japan (JP)

2

Name:
HIRAISHI, Yasuhiro
Address:
Japan (JP)

Priority

Priority Number:
2008194219
Priority Date:
28/07/2008
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 9/14; A61K 9/16; A61K 9/20; A61K 9/28; A61K 9/48; A61K 31/4427; A61K 47/02; A61K 47/12; A61K 47/36; A61K 47/38; A61K 47/10;

Publication

European Patent Bulletin

Issue number:
201811
Publication date:
14/03/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/11/2018 Outgoing Correspondence 1